Latest News
Earnings To Watch: Armstrong World (AWI) Reports Q3 Results Tomorrow
Carlisle (NYSE:CSL) Reports Sales Below Analyst Estimates In Q3 Earnings, Stock Drops
Carlisle (CSL) Q3 Earnings Report Preview: What To Look For
Q2 Rundown: UFP (NASDAQ:UFPI) Vs Other Building Materials Stocks
Q2 Earnings Outperformers: Valmont (NYSE:VMI) And The Rest Of The Building Materials Stocks
We are looking for U.S. based non-financial that offer quality at a fair price
Winners And Losers Of Q2: Carlisle (NYSE:CSL) Vs The Rest Of The Building Materials Stocks
3 Best Vanguard Stock ETFs to Buy in August
These Vanguard funds could benefit from two key tailwinds this month.
The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.54%. Stock indexes this morning recovered from early losses and are posting moderate gains....
The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.14%. Stock indexes this morning are mixed. Higher bond yields are negative for stocks...
The Chart of the Day belongs to the building products and equipment company Carlisle Companies (CSL) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then...
Health Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
/CNW/ -- Global biotechnology leader CSL (ASX: CSL) today announced that Health Canada has authorized HEMGENIX® (etranacogene dezaparvovec), the first and only...
New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines
Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among...
CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems
Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following...
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season
CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the...
4 Industrial Stocks That Are Screaming Buys in June
These vital manufacturers could produce stellar returns.
Carlisle Companies Declares Regular Quarterly Dividend
Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on June 1, 2023, to shareholders of record at the close of business on May 17, 2023.
Carlisle Companies Elects C. David Myers to its Board of Directors
Carlisle Companies Incorporated (NYSE:CSL) announced today that C. David Myers has been elected to its Board of Directors effective immediately.
Carlisle Companies Announces May 2023 Events with the Financial Community
Carlisle Companies Incorporated (NYSE:CSL) today announced participation in the following upcoming events with the financial community in the month of May:
Carlisle Companies Reports First Quarter Results
Carlisle Companies Incorporated (NYSE:CSL) today announced its first quarter 2023 financial results.